Acute Lymphoblastic Leukemia Version 3.2024
Acute Myeloid Leukemia Version 1.2025
Ampullary Adenocarcinoma Version 1.2025
Anal Carcinoma Version 1.2025
B-Cell Lymphomas Version 1.2025
Biliary Tract Cancers Version 5.2024
Castleman Disease Version 1.2025
Cervical Cancer Version 1.2025
Chronic Myeloid Leukemia Version 3.2025
Esophageal and Esophagogastric Junction Cancers Version 5.2024
Gastric Cancer Version 5.2024
Gestational Trophoblastic Neoplasia Version 1.2025
Head and Neck Cancers Version 1.2025
Hodgkin Lymphoma Version 1.2025
Melanoma: Cutaneous Version 1.2025
Non-Small Cell Lung Cancer Version 1.2025
Pancreatic Adenocarcinoma Version 1.2025
Pediatric Acute Lymphoblastic Leukemia Version 2.2025
Prostate Cancer Version 1.2025
Small Bowel Adenocarcinoma Version 1.2025
Uterine Neoplasms Version 1.2025
Vaginal Cancer Version 3.2025
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Version 2.2025
NCCN Guidelines with Evidence Blocks - Anal Carcinoma Version 1.2025
NCCN Guidelines with Evidence Blocks - Biliary Tract Cancers Version 5.2024
NCCN Guidelines with Evidence Blocks - Chronic Myeloid Leukemia Version 3.2025
NCCN Guidelines with Evidence Blocks - Head and Neck Cancers Version 1.2025
NCCN Guidelines with Evidence Blocks - Small Bowel Adenocarcinoma Version 1.2025
NCCN Guidelines with Evidence Blocks - Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Version 2.2025
Adult Cancer Pain Version 3.2024
Management of Immunotherapy-Related Toxicities Version 1.2025
Survivorship Version 2.2024
Older Adult Oncology Version 1.2025